Pharmaceutical manufacturing

FILE - This April 26, 2017, file photo shows the Eli Lilly & Co. corporate headquarters in Indianapolis. Eli Lilly is buying Loxo Oncology for about $8 billion as it continues to broaden its cancer treatment efforts. Loxo Oncology Inc. is a biopharmaceutical company focused on the development and commercialization of highly selective medicines for patients with genomically defined cancers. (AP Photo/Darron Cummings, File)
January 07, 2019 - 7:49 am
Eli Lilly is spending about $8 billion in cash to buy Loxo Oncology, as the drugmaker bulks up on cancer treatments that target certain gene abnormalities. Loxo Oncology could launch a drug next year and targets an abnormality that occurs in several tumor types, including some lung and thyroid...
Read More
FILE - In this June 15, 2005, file photo, a sign stands in front of a Bristol-Myers Squibb building in a Lawrence Township, N.J. Bristol-Myers Squibb is buying Celgene in a cash-and-stock deal valued at about $74 billion. (AP Photo/Mel Evans, File)
January 03, 2019 - 6:00 pm
SUMMIT, N.J. (AP) — Bristol-Myers Squibb is spending $74 billion on fellow drugmaker Celgene in a deal aimed at stocking the combined company's development pipeline with cancer, immunology and cardiovascular treatments. Bristol would gain the cancer treatment Revlimid in the cash-and-stock deal...
Read More
FILE - This April 20, 2009 file photo, shows the British pharmaceuticals firm GlaxoSmithKline in London. Drugmakers GlaxoSmithKline and Pfizer are merging their healthcare divisions, creating a business with combined sales of 9.8 billion pounds ($12.7 billion). British-based Glaxo will own 68 percent of the joint venture, while U.S.-based Pfizer will own the remaining 32 percent stake. (AP Photo/Sang Tan, File)
December 19, 2018 - 1:18 pm
Drugmakers GlaxoSmithKline and Pfizer plan to merge their consumer health businesses into what will be the world leader in sales of nonprescription medicines such as pain relievers, vitamins and cold remedies. The new joint venture would have with combined annual sales of $12.7 billion (9.8 billion...
Read More
FILE- In this Nov. 20, 2018, file photo pedestrians walk past the New York Stock Exchange. The U.S. stock market opens at 9:30 a.m. EST on Friday, Nov. 30 (AP Photo/Mary Altaffer, File)
November 30, 2018 - 1:51 pm
NEW YORK (AP) — Stocks are wavering Friday ahead of the highly anticipated trade meeting between President Donald Trump and President Xi Jinping of China. Investors have long hoped the two will use their meeting at the Group of 20 summit to start resolving the trade dispute between the two...
Read More
November 23, 2018 - 9:01 am
LONDON (AP) — A British corporate investigator has complained to U.K. regulators about Chinese state TV, saying its British license should be revoked because it broadcast his forced confession when he was imprisoned in China. Peter Humphrey filed a complaint Friday against China Central Television...
Read More
FILE - In this Tuesday, Oct. 23, 2018, file photo trader Peter Tuchman, center, works on the floor of the New York Stock Exchange. The U.S. stock market opens at 9:30 a.m. EDT on Monday, Nov. 5. (AP Photo/Richard Drew, File)
November 05, 2018 - 3:15 pm
NEW YORK (AP) — U.S. stocks are rising Monday as Warren Buffett's Berkshire Hathaway leads gains in insurers and other financial companies. Health care companies are also rising, led by drugmakers. Technology and internet companies continue to struggle as Apple drops again. Asian indexes fell...
Read More
FILE - In this Dec. 14, 2017 file photo, an Israeli flag flies outside a Teva Pharmaceutical Industries building, in Neot Hovav, Israel. On Thursday, Nov. 1, 2018, Israeli drug maker Teva reported a third-quarter loss as it proceeds with an aggressive cost-cutting program and adjusts to declines in key product categories. But the company gave an upbeat outlook, citing stabilization in its core generics business, the launch of new products and progress with its restructuring program. Its stock price surged on the news. (AP Photo/Tsafrir Abayov, File)
November 01, 2018 - 1:12 pm
JERUSALEM (AP) — Israeli drug maker Teva Pharmaceutical Industries on Thursday reported a third-quarter loss as it proceeds with an aggressive cost-cutting program and adjusts to declines in key product categories. But the company gave an upbeat outlook, citing stabilization in its core generics...
Read More
In this photo taken Monday, Sept. 24, 2018, Adrian Perez undergoes dialysis at a DaVita Kidney Care clinic in Sacramento, Calif. Dialysis companies have contributed an extraordinary $111 million and counting to defeat a California ballot initiative that would cap their profits, the most any one side has spent on a U.S. ballot issue since at least 2002. (AP Photo/Rich Pedroncelli)
October 26, 2018 - 6:24 pm
SACRAMENTO, Calif. (AP) — Dialysis companies have contributed an extraordinary $111 million and counting to defeat a California ballot initiative that would cap their profits, the most any one side has spent on a U.S. ballot issue since at least 2002. A $5 million donation from this week from...
Read More
President Donald Trump talks about drug prices during a visit to the Department of Health and Human Services in Washington, Thursday, Oct. 25, 2018. (AP Photo/Susan Walsh)
October 26, 2018 - 1:13 am
WASHINGTON (AP) — Less than two weeks before the midterm elections, President Donald Trump has announced a plan to lower prices for some prescription drugs, saying it would stop unfair practices that force Americans to pay much more than people in other countries for the same medications. "We are...
Read More
President Donald Trump talks about drug prices during a visit to the Department of Health and Human Services in Washington, Thursday, Oct. 25, 2018. (AP Photo/Susan Walsh)
October 25, 2018 - 6:10 pm
WASHINGTON (AP) — Less than two weeks before the midterm elections, President Donald Trump on Thursday announced a plan to lower prices for some prescription drugs, saying it would stop unfair practices that force Americans to pay much more than people in other countries for the same medications. "...
Read More

Pages